Page last updated: 2024-08-25

doripenem and Infections, Staphylococcal

doripenem has been researched along with Infections, Staphylococcal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Micek, ST; Neuner, EA; Ritchie, DJ	1
Kobayashi, Y	1

Reviews

1 review(s) available for doripenem and Infections, Staphylococcal

Article	Year
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009

Article

Year

New antibiotics for healthcare-associated pneumonia.

Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1

Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin

2009

Other Studies

1 other study(ies) available for doripenem and Infections, Staphylococcal

Article	Year
Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2005

Article

Year

Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:5

Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2005